These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33787865)

  • 41. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease.
    Chamberlain AM; Cohen SS; Weston SA; Fox KM; Xiang P; Killian JM; Qian Y
    Am J Cardiol; 2019 Jun; 123(11):1739-1744. PubMed ID: 30948001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.
    Wake M; Oh A; Onishi Y; Guelfucci F; Shimasaki Y; Teramoto T
    Atherosclerosis; 2019 Mar; 282():19-28. PubMed ID: 30669019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
    Malmborg M; Schmiegelow MDS; Gerds T; Schou M; Kistorp C; Torp-Pedersen C; Gislason G
    J Am Heart Assoc; 2021 Jul; 10(13):e020395. PubMed ID: 34151606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study.
    Rezende Macedo do Nascimento RC; Mueller T; Godman B; MacBride Stewart S; Hurding S; de Assis Acurcio F; Guerra Junior AA; Alvares Teodoro J; Morton A; Bennie M; Kurdi A
    Br J Clin Pharmacol; 2020 Dec; 86(12):2349-2361. PubMed ID: 32353163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
    Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
    Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With Dementia.
    Ofori-Asenso R; Ilomaki J; Tacey M; Curtis AJ; Zomer E; Bell JS; Zoungas S; Liew D
    Am J Alzheimers Dis Other Demen; 2018 Dec; 33(8):527-534. PubMed ID: 29991271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico.
    Hernández-Muñoz JJ; Wong ES; Kamdar CR
    J Manag Care Spec Pharm; 2021 Mar; 27(3):392-398. PubMed ID: 33645248
    [No Abstract]   [Full Text] [Related]  

  • 51. Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan.
    Shau WY; Lai CL; Huang ST; Chen ST; Li JZ; Fung S; Tse VC; Lai MS
    Heart Asia; 2019; 11(2):e011176. PubMed ID: 31565075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Impact of adherence to statins on cardiovascular adverse events in patients with coronary artery disease: a meta-analysis].
    Li ST; Xu JY; Huang RC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Aug; 44(8):684-90. PubMed ID: 27545127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statin adherence and mortality in patients enrolled in a secondary prevention program.
    McGinnis BD; Olson KL; Delate TM; Stolcpart RS
    Am J Manag Care; 2009 Oct; 15(10):689-95. PubMed ID: 19845421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events.
    Tecson KM; Kluger AY; Cassidy-Bushrow AE; Liu B; Coleman CM; Jones LK; Jefferson CR; VanWormer JJ; McCullough PA
    Am J Cardiol; 2022 Aug; 176():37-42. PubMed ID: 35606173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe.
    Rea F; Savaré L; Corrao G; Mancia G
    Adv Ther; 2021 Oct; 38(10):5270-5285. PubMed ID: 34480293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
    Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
    Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings.
    Shalev V; Goldshtein I; Halpern Y; Chodick G
    Pharmacotherapy; 2014 Jan; 34(1):1-8. PubMed ID: 23836549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between trajectories of statin adherence and subsequent cardiovascular events.
    Franklin JM; Krumme AA; Tong AY; Shrank WH; Matlin OS; Brennan TA; Choudhry NK
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1105-13. PubMed ID: 25903307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.